Restoring Dystrophin Expression with Duchenne Muscular Dystrophy Exon 45 Skipping in Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Methods Mol Biol. 2023:2587:141-151. doi: 10.1007/978-1-0716-2772-3_8.

Abstract

Induced pluripotent stem cell (iPSC)-based disease model is a useful tool that can represent the pathophysiology of patient organs that are inaccessible due to invasiveness. Here, we present a method to induce differentiation of Duchenne muscular dystrophy (DMD) patient-derived iPSCs into cardiomyocytes and restore dystrophin expression by exon skipping using antisense nucleic acids. This involves a 20-day multi-step culture process for differentiation to cardiomyocytes, followed by exon-skipping experiments. Additionally, RT-PCR, western blotting, and immunocytochemistry are used to confirm the restoration of dystrophin expression.

Keywords: Antisense oligonucleotide (ASO); Cardiomyocytes; Cell culture; Duchenne muscular dystrophy (DMD); Exon skip; Immunocytochemistry; Induced pluripotent stem cells (iPSCs); RT-PCR; Western blotting.

MeSH terms

  • Dystrophin / genetics
  • Dystrophin / metabolism
  • Exons / genetics
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Muscular Dystrophy, Duchenne* / genetics
  • Muscular Dystrophy, Duchenne* / metabolism
  • Muscular Dystrophy, Duchenne* / therapy
  • Myocytes, Cardiac / metabolism

Substances

  • Dystrophin